We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£490.00
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 3 months
Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 23 days · 23 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 23 days • 1 price levels
Price Analysis
Most common price: £490 (23 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 23 days
Description
Key Features
Provides latent demand outlook for non-Hodgkin lymphoma treatments across U.S. states and zip codes from 2023 to 2028.
Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for 10,833 different zip codes.
Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the entire United States.
Supports distribution and sales force strategies through detailed statistical analysis of market demand.
Delivered by manufacturer ICON Group International, Inc. for professional industry use.
Product Specifications
- Format
- paperback
- ASIN
- B0BSWDVR31
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 27 January 2023
Similar Products You Might Like
Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028
Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
The 2023-2028 Outlook for Lymphoma Treatments in China
Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study
The 2023-2028 Outlook for Lymphoma Treatments in the United States
The 2023-2028 Outlook for Lymphoma Treatments in India
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
Head and Neck Oncology Nutrition Outlook 2023-2028 Study
Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
